Article
Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients.
Antiviral therapy - 1 Jan 2017
Backus Lisa I, Belperio Pamela S, Shahoumian Troy A, Loomis Timothy P, Mole Larry A
Abstract excerpt
BACKGROUND: Predictors of sustained virological response (SVR) to all-oral HCV regimens can inform nuanced treatment decisions. We evaluated effectiveness and identified predictors of SVR for ledipasvir/sofosbuvir ± ribavirin (LDV/SOF ±RBV) and ombitasvir/paritaprevir/ritonavir + dasabuvir (OPrD) ±RBV in patients treated in routine practice. METHODS: Observational, intent-to-treat cohort of 21,142 genotype-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
